Skip to Main Navigation

Cambodia COVID-19 Emergency Response Project

Development Objective

To assist Cambodia in its efforts to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness.

Key Details

Project Details

  • P173815

  • Active

  • Nareth Ly

  • Kingdom of Cambodia

  • Cambodia

  • March 30, 2020

  • (as of board presentation)

    April 2, 2020

  • April 6, 2020

  • US$ 20.00 million

  • Ministry of Health Cambodia

  • East Asia and Pacific

  • 2020

  • US$ 24.65 million

  • N/A

  • May 26, 2024

  • September 30, 2025

  • No

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 20.00
Pandemic Emergency Financing Facility 1.15
Health Emergency Preparedness and Response Multi-Donor Trust 3.50

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 20.00
IBRD + IDA Commitment 20.00
Lending Instrument
Grant Amount 4.65
Total Project Cost** 20.00

Summary Status of World Bank Financing (US$ Millions) as of January 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of January 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Apr 2, 2020 IDA-65960 Loan Commitment 20,000,000.00
Apr 1, 2024 IDA-65960 Int Charges 1,312.42
Apr 1, 2024 IDA-65960 Int Charges 1,312.42
Apr 1, 2024 IDA-65960 Int Charges 67,892.75
Apr 1, 2024 IDA-65960 Int Charges 67,892.75
Jun 21, 2024 IDA-65960 Loan Disb 1,355,171.90
May 6, 2024 IDA-65960 Loan Disb -600,000.00
Oct 1, 2023 IDA-65960 Int Charges 69,450.42
Oct 1, 2023 IDA-65960 Int Charges 69,450.42
Oct 1, 2023 IDA-65960 Int Charges 334.86
Oct 1, 2023 IDA-65960 Int Charges 334.86
Oct 10, 2023 IDA-65960 Loan Disb -290,334.38
Oct 1, 2022 IDA-65960 Int Charges 941.17
Oct 1, 2022 IDA-65960 Int Charges 941.17
Oct 1, 2022 IDA-65960 Int Charges 67,181.45
Oct 1, 2022 IDA-65960 Int Charges 67,181.45
Apr 1, 2023 IDA-65960 Int Charges 68,998.97
Apr 1, 2023 IDA-65960 Int Charges 68,998.97
Apr 1, 2023 IDA-65960 Int Charges 2,388.25
Apr 1, 2023 IDA-65960 Int Charges 2,388.25
Sep 27, 2022 IDA-65960 Loan Disb -0.50
Sep 27, 2022 IDA-65960 Loan Disb -38,560.01
Feb 5, 2021 IDA-65960 Loan Disb 528,000.00
Dec 11, 2020 IDA-65960 Loan Disb 864,733.30
Oct 28, 2021 IDA-65960 Loan Disb 1,727,999.10
Oct 26, 2021 IDA-65960 Loan Disb -20,211.35
Apr 1, 2021 IDA-65960 Int Charges 336.97
Apr 1, 2021 IDA-65960 Int Charges 336.97
Jul 19, 2021 IDA-65960 Loan Disb 1,417,500.00
Aug 6, 2021 IDA-65960 Loan Disb 76,163.46
Oct 1, 2021 IDA-65960 Int Charges 387.18
Oct 1, 2021 IDA-65960 Int Charges 387.18
Oct 1, 2021 IDA-65960 Int Charges 57,494.21
Oct 1, 2021 IDA-65960 Int Charges 57,494.21
Oct 26, 2021 IDA-65960 Loan Disb -0.01
Aug 9, 2021 IDA-65960 Loan Disb 1,766,332.60
Jun 7, 2022 IDA-65960 Loan Disb -41,698.04
Apr 1, 2022 IDA-65960 Int Charges 1,265.79
Apr 1, 2022 IDA-65960 Int Charges 1,265.79
Apr 1, 2022 IDA-65960 Int Charges 72,634.53
Apr 1, 2022 IDA-65960 Int Charges 72,634.53
Sep 9, 2020 IDA-65960 Loan Disb 802,966.70
Jun 2, 2020 IDA-65960 Loan Disb 1,054,035.60
Jun 29, 2020 IDA-65960 Loan Disb 3,029,005.00
Jun 19, 2020 IDA-65960 Loan Disb 607,500.00
Oct 1, 2020 IDA-65960 Int Charges 18,240.46
May 11, 2021 IDA-65960 Loan Disb 1,782,665.90
May 11, 2021 IDA-65960 Loan Disb 685,471.25
Feb 17, 2021 IDA-65960 Loan Disb 481,893.00
Jan 13, 2021 IDA-65960 Loan Disb 161,803.62
Oct 1, 2020 IDA-65960 Int Charges 18,240.46
Jul 13, 2020 IDA-65960 Loan Disb 5,000,000.00
Apr 1, 2021 IDA-65960 Int Charges 43,143.93
Apr 1, 2021 IDA-65960 Int Charges 43,143.93

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Procurement Satisfactory 2024-12-27
Progress towards achievement of PDO Satisfactory 2024-12-27
Project Management Satisfactory 2024-12-27
Financial Management Satisfactory 2024-12-27
Monitoring and Evaluation Satisfactory 2024-12-27
Progress towards achievement of PDO Satisfactory 2024-12-27
Project Management Satisfactory 2024-12-27
Financial Management Satisfactory 2024-12-27
Monitoring and Evaluation Satisfactory 2024-12-27
Overall Implementation Progress (IP) Moderately Satisfactory 2024-12-27
Procurement Satisfactory 2024-12-27
Overall Implementation Progress (IP) Moderately Satisfactory 2024-12-27

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagentsValue1.0015.002.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of provincial hospitals with adequate supply of PPE to manage 30 COVID-19 cases and undertake outbreak investigationsValue0.0025.0025.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of acute healthcare facilities with isolation capacityValue0.0030.0025.00
    DateMarch 19, 2020November 30, 2023December 31, 2022
    Comment
  • Percentage of population vaccinated, which is included in the priority population groups defined in national plan.Value0.0015.0015.00
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Percentage of population vaccinated, which is included in the priority population groups defined in national plan(Female)Value0.007.597.50
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Percentage of population vaccinated, which is included in the priority population groups defined in national plan (Male)Value0.007.417.50
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of complaints to the Grievance Redress Mechanism (GRM) satisfactorily addressed within 15 weeks of initial complaint being recordedValue0.000.0080.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Standard design for provincial hospital isolation and treatment centers is finalizedValueNoYesYes
    DateMarch 19, 2020May 10, 2024December 31, 2024
    Comment
  • Daily capacity of NIPH in conducting COVID-19 or similar testsValue100.006000.00400.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Percentage of EOCs functioning at national, province and district levelValue0.00100.0080.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Message and material developed to build awareness in the event of a pandemic infectious disease outbreakValueNoYesYes
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of provincial hospitals with functioning isolation and treatment centersValue0.0025.0025.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of laboratories at provincial referral hospitals equipped per national guidelineValue0.0025.0025.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Percentage of healthcare workers trained in clinical management/infection prevention and controlValue0.00100.0080.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of bio-safety level 2+ laboratory established at regional laboratoryValue0.002.002.00
    DateJuly 15, 2020May 10, 2024December 31, 2022
    Comment
  • Percentage of healthcare workers trained in surveillance and investigationValue0.0088.0080.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of call centers established and functioningValue10.00128.00100.00
    DateMarch 19, 2020May 10, 2024December 31, 2022
    Comment
  • Number of health facilities at the provincial level having cold chain facilities prior to receipt of vaccineValue0.0010.0010.00
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Number of bio-safety level 3 lab establishedValue1.001.002.00
    DateMarch 19, 2020May 10, 2024December 31, 2024
    Comment
  • Percentage of operational districts having micro-plans in place before vaccines are deliveredValue0.00100.00100.00
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Percentage of people in target groups registered before vaccination rollout begins, disaggregated by genderValue0.00100.0017.00
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Percentage of people in target groups registered before vaccination rollout begins (female)Value0.0051.108.50
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment
  • Percentage of people in target groups registered before vaccination rollout begins (male)Value0.0048.908.50
    DateMarch 1, 2021May 10, 2024December 31, 2022
    Comment